Literature DB >> 23178552

Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease.

Alexandra K Leamy1, Robert A Egnatchik, Jamey D Young.   

Abstract

The steady rise in Western obesity rates has been closely linked to significant increases in a multitude of accompanying health problems including non-alcoholic fatty liver disease (NAFLD). NAFLD severity ranges from simple steatosis to acute steatohepatitis, but the molecular mechanisms controlling progression of this disease are poorly understood. Recent literature suggests that elevated free fatty acids (FFAs), especially saturated FFAs, may play an important role in lipotoxic mechanisms, both in experimental models and in NAFLD patients. This review highlights important cellular pathways involved in hepatic lipotoxicity and how the degree of intrahepatic lipid saturation controls cell fate in response to an elevated FFA load. Relevant cellular processes that have been causally linked to lipid-induced apoptosis, known as lipoapoptosis, include endoplasmic reticulum (ER) stress, oxidative stress, mitochondrial dysfunction, and Jun N-terminal kinase (JNK) signaling. In contrast, increased triglyceride synthesis has been shown to have a protective effect against lipotoxicity, despite being one of the hallmark traits of NAFLD. Developing a more nuanced understanding of the molecular mechanisms underlying NAFLD progression will lead to more targeted and effective therapeutics for this increasingly prevalent disease, which to date has no proven pharmacologic treatment to prevent or reverse its course.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178552      PMCID: PMC3868987          DOI: 10.1016/j.plipres.2012.10.004

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  109 in total

1.  Bip overexpression, but not CHOP inhibition, attenuates fatty-acid-induced endoplasmic reticulum stress and apoptosis in HepG2 liver cells.

Authors:  Xuemei Gu; Kwan Li; D Ross Laybutt; Ming-liang He; Hai-Lu Zhao; Juliana C N Chan; Gang Xu
Journal:  Life Sci       Date:  2010-10-21       Impact factor: 5.037

2.  Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells.

Authors:  Michalis D Mantzaris; Epameinondas V Tsianos; Dimitrios Galaris
Journal:  FEBS J       Date:  2010-12-23       Impact factor: 5.542

3.  Fatty acid-induced oxidation and triglyceride formation is higher in insulin-producing MIN6 cells exposed to oleate compared to palmitate.

Authors:  Kristofer Thörn; Peter Bergsten
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

4.  Stimulation of lipogenesis as well as fatty acid oxidation protects against palmitate-induced INS-1 beta-cell death.

Authors:  Sung-E Choi; Ik-Rak Jung; Youn-Jung Lee; Soo-Jin Lee; Ji-Hyun Lee; Youngsoo Kim; Hee-Sook Jun; Kwan-Woo Lee; Chan Bae Park; Yup Kang
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

5.  Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.

Authors:  Patricia Iozzo; Marco Bucci; Anne Roivainen; Kjell Någren; Mikko J Järvisalo; Jan Kiss; Letizia Guiducci; Barbara Fielding; Alexandru G Naum; Ronald Borra; Kirsi Virtanen; Timo Savunen; Piero A Salvadori; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Journal:  Gastroenterology       Date:  2010-05-25       Impact factor: 22.682

6.  Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.

Authors:  Claudia O Zein; Lisa M Yerian; Prema Gogate; Rocio Lopez; John P Kirwan; Ariel E Feldstein; Arthur J McCullough
Journal:  Hepatology       Date:  2011-08-24       Impact factor: 17.425

7.  Modulation of lipid-induced ER stress by fatty acid shape.

Authors:  Julie Deguil; Ludovic Pineau; Ellen Claire Rowland Snyder; Sébastien Dupont; Laurent Beney; Adrià Gil; Gilles Frapper; Thierry Ferreira
Journal:  Traffic       Date:  2011-01-07       Impact factor: 6.215

8.  Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid.

Authors:  M Miyazaki; W C Man; J M Ntambi
Journal:  J Nutr       Date:  2001-09       Impact factor: 4.798

9.  Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia.

Authors:  M E Visser; N M Lammers; A J Nederveen; M van der Graaf; A Heerschap; M T Ackermans; H P Sauerwein; E S Stroes; M J Serlie
Journal:  Diabetologia       Date:  2011-05-06       Impact factor: 10.122

10.  Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.

Authors:  D Lee Gorden; Pavlina T Ivanova; David S Myers; J Oliver McIntyre; Michael N VanSaun; J Kelly Wright; Lynn M Matrisian; H Alex Brown
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

View more
  136 in total

1.  Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.

Authors:  Hussam Alamri; Nathan Heath Patterson; Ethan Yang; Pablo Zoroquiain; Anthoula Lazaris; Pierre Chaurand; Peter Metrakos
Journal:  Anal Bioanal Chem       Date:  2018-12-05       Impact factor: 4.142

2.  Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio.

Authors:  Zengsheng Lu; Fengbin Lu; Liyan Wu; Beihui He; Zhiyun Chen; Maoxiang Yan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-10       Impact factor: 3.000

3.  Development of a classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy.

Authors:  Jie Yan; Yang Yu; Jeon Woong Kang; Zhi Yang Tam; Shuoyu Xu; Eliza Li Shan Fong; Surya Pratap Singh; Ziwei Song; Lisa Tucker-Kellogg; Peter T C So; Hanry Yu
Journal:  J Biophotonics       Date:  2017-06-21       Impact factor: 3.207

4.  Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.

Authors:  Sanda Win; Tin Aung Than; Bao Han Allison Le; Carmen García-Ruiz; Jose C Fernandez-Checa; Neil Kaplowitz
Journal:  J Hepatol       Date:  2015-02-07       Impact factor: 25.083

5.  The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD.

Authors:  Milena N Stanković; Dušan Mladenović; Milica Ninković; Ivana Ethuričić; Slađana Sobajić; Bojan Jorgačević; Silvio de Luka; Rada Jesic Vukicevic; Tatjana S Radosavljević
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

Review 6.  Modulation of hepatic steatosis by dietary fatty acids.

Authors:  Alessandra Ferramosca; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes.

Authors:  Robert A Egnatchik; Alexandra K Leamy; Yasushi Noguchi; Masakazu Shiota; Jamey D Young
Journal:  Metabolism       Date:  2013-10-24       Impact factor: 8.694

Review 8.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway.

Authors:  Qian Chen; Mengyang Liu; Haiyang Yu; Jian Li; Sijian Wang; Yi Zhang; Feng Qiu; Tao Wang
Journal:  J Nat Med       Date:  2018-03-14       Impact factor: 2.343

10.  The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Authors:  April D Lake; Petr Novak; Rhiannon N Hardwick; Brieanna Flores-Keown; Fei Zhao; Walter T Klimecki; Nathan J Cherrington
Journal:  Toxicol Sci       Date:  2013-10-04       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.